Was hoping for a " First patient dosed " anns, still some hurdles to come. Probably July? Anyway, better late than never. 3rd generation, auto or allo? Allo is now the way to go but when licensed it wasn't that popular. Maybe they can use allo as well, in the end is just a matter of availability of healthy donor cells or they may use the placenta based cells developed by CELU.
Time will tell.
GLTA
Ann: CHM CDH17 Phase 1/2 clinical trial approved for initiation, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.323M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $26.66K | 8.722M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 72 | 71177716 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 94220096 | 28 |
View Market Depth
| Last trade - 14.10pm 28/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |